Navigation Links
Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
Date:5/26/2011

of our MAA filing before the EMA and market demand within the European Union are forward-looking statements. These forward-looking statements involve substantial risks and uncertainties and are based on our assessment and interpretation of the currently available data and information, current expectations, assumptions, estimates and projections about our business and the biopharmaceutical and specialty pharmaceutical industries in which we operate. Important factors that may affect our ability to achieve the matters addressed in these forward-looking statements include, but are not limited to, our ability to commercialize KRYSTEXXA; our ability to retain the personnel whom we have hired and to hire the remaining personnel necessary to complete the build out of our commercial team; our reliance on third parties to manufacture KRYSTEXXA; the risk that the market for KRYSTEXXA is smaller than we have anticipated; competition from existing therapies and therapies that are currently under development, including therapies that are significantly less expensive than KRYSTEXXA; our ability to gain market acceptance for KRYSTEXXA among physicians, patients, health care payors and others in the medical community; whether we are able to obtain financing, if needed; economic, political and other risks associated with foreign operations; risks of maintaining protection for our intellectual property; risks of an adverse determination in intellectual property litigation; and risks associated with stringent government regulation of the biopharmaceutical industry and other important factors set forth more fully in our reports filed with the Securities and Exchange Commission, to which investors are referred for further information. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements, which speak only as of the date of publication of this press release.
'/>"/>
SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)...   BioNano Genomics , the genome mapping ... to purchase an Irys™ System . Among them ... (NCI), NIH Intramural Sequencing Center (NISC) and Genoscope (The ... comprehensive view of a genome was a major ... deliver the scalability or reliability to detect and ...
(Date:10/22/2014)... Oct. 21, 2014 Influenza will affect as many ... the United States as high as ... to spread is from person to person in respiratory droplets ... serve way of death, but kills much fewer people each ... done by human fluids including sweat, saliva, blood and other ...
(Date:10/22/2014)... 2014 Sanomedics International Holdings, Inc. (OTCQB: SIMH) ... Research & Data Services, demand for thermometers is expected ... 2018, as demand for more accurate digital thermometers continues.  ... world,s largest market for thermometers, and one of the ... International Holdings, Inc. Sanomedics International Holdings designs, ...
Breaking Medicine Technology:BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test 2Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2
(Date:10/25/2014)... 26, 2014 The past five ... Sugar Cane Growing industry in Australia . ... by extreme weather patterns, volatile commodity prices and ... industry analyst Brooke Tonkin, “Over the period, flooding ... of Australia's sugar cane crop.” Consequently, industry revenue ...
(Date:10/25/2014)... 25, 2014 Triton Algae Innovations, ... announced Dr. Xun Wang has joined the ... Development. , Triton has developed a patented synthetic biology ... According to Dr. Wang, the platform uses algae to ... He says, “Algae are unique because they can produce ...
(Date:10/25/2014)... 26, 2014 BioSkinLaser.Com, the leading and ... advanced and improved laser treatments for its customers. BioSkinLaser ... like the lip enhancement treatment . It offers ... focus areas of each customer. , BioSkinLaser.Com has also ... NYC . The company cited that it created the ...
(Date:10/25/2014)... The proposed consolidation of all federally-filed ... December, when the U.S. Judicial Panel on Multidistrict Litigation ... Hearing Session Order issued by the Panel on October ... on December 4, 2014, in Charleston, South Carolina. The ... Xarelto Products Liability Litigation, No. 2592) , “Our Firm ...
(Date:10/25/2014)... The global HCIT outsourcing market is forecast to ... billion by 2018 from $35 billion in 2013. The ... are driving the HCIT outsourcing market. These industries follow ... core business, reduce operational and maintenance costs, increase access ... and training costs), share risk, and quickly implement new ...
Breaking Medicine News(10 mins):Health News:Sugar Cane Growing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Sugar Cane Growing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 2Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 3Health News:BioSkinLaser.Com Now Offers Advanced Medical Aesthetics Procedures 2Health News:BioSkinLaser.Com Now Offers Advanced Medical Aesthetics Procedures 3Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 2Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 4
... in some way. For some people, the most convenient ... in exercise machines to help burn calories and increase ... preferences, budget and health, some aerobic exercise machines may ... of Mayo Clinic Health Letter covers some options: ...
... a clear indication in a scientific journal regarding a ... the drug was tested on human participants, which turned ... timely emergency care services, the participants would have been ... reasons for the mishap of the trial, blamed gross ...
... of Newcastle disease on an East Lothian farm has led to ... // is usually fatal for birds and a 3km protection zone ... Fenton Barns, Drem, to prevent its spread. ,According to ... not linked to bird flu. However it can spread rapidly in ...
... the funds that was provided by the US administration ... to men in Swaziland. ,According to the U.S. ... of the program and that it violated government policy ... procedure. ,Over the past 12 months around 300 ...
... surgery was made at a major conference on brain tumours ... , ,According to the Irish Cancer Society, in spite ... higher rate of success and any damge to the delicate ... that there were 316 new cases of primary brain tumour ...
... advanced nations of the world today, Britain had to face ... in Europe' last week. //In a recent report by CABE ... of the nation's population can be declared obese and overweight. ... (CABE) with its headquarters in London works towards improving people's ...
Cached Medicine News:Health News:Home Is Where the Gym Is 2Health News:Bush Administration Proposes End of Funding of Anti-AIDS Program in Swaziland 2Health News:Awake Surgery to treat Brain tumours 2
... tip, the Finntip Wide is designed especially ... like genomic DNA. This tip eliminates the ... is excellent for use with extremely viscous ... diameter of the orifice is 1.1 mm ...
For restriction digests, immuno-precipitations, enzyme assays, TLC spotting and others...
The Ultra Micro tip for the Eppendorf and Nichiryo/BenchMate 0.5-10 L pipettors is perfect for working with low volume samples....
... easy way to order tips. Each box contains ... D10mL, which contains 200 tips (4 bags of ... Packs of 200 tips per pack. Bulk Packs ... easily be opened for quick access to Gilsons ...
Medicine Products: